XML 26 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income $ 32,648 $ 37,367
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 26,495 21,105
Non-cash lease expense 1,939 2,200
Amortization of marketing contract intangible 1,803 1,803
Amortization of deferred revenue (572) (444)
Amortization of deferred financing costs and debt discount 1,250 1,127
Income from equity method investments (8,490) (6,316)
Dividends from equity method investments 9,509 9,238
Loss on extinguishment of debt 3,571 0
Other non-cash adjustments 1,492 780
Changes in assets and liabilities:    
Accounts receivable (15,862) 2,165
Inventories and other current assets 670 (1,482)
Accounts payable and other current liabilities (2,359) (36,430)
Accounts receivable/payable to related parties (8,145) (1,578)
Non-current assets and liabilities, net (91) (345)
Net cash provided by operating activities 43,858 29,190
Cash flows from investing activities:    
Purchases of property, plant and equipment (11,255) (27,837)
Proceeds from sales of property, plant and equipment 42 0
Purchases of intangible assets (781) (582)
Distributions from equity method investments 2,133 1,440
Net cash used in investing activities (9,861) (26,979)
Cash flows from financing activities:    
Distributions to common unitholders - public (10,012) (9,442)
Distributions to common unitholders - Delek Holdings (36,198) (34,998)
Proceeds from term debt 650,000 0
Payments on term debt (531,250) (3,750)
Proceeds from revolving facility 184,900 143,500
Payments on revolving facility (400,200) (93,400)
Proceeds from issuance of units 132,327 0
Payments on other financing agreements (6,214) 0
Deferred financing costs paid (10,946) (400)
Other financing activities (487) (727)
Net cash (used in) provided by financing activities (28,080) 783
Net increase in cash and cash equivalents 5,917 2,994
Cash and cash equivalents at the beginning of the period 3,755 7,970
Cash and cash equivalents at the end of the period 9,672 10,964
Cash paid during the period for:    
Interest 28,503 20,210
Non-cash investing activities:    
Increase in accrued capital expenditures 3,910 8,258
Non-cash financing activities:    
Non-cash lease liability arising from obtaining right of use assets during the period $ 537 $ 3,456